ClinicalTrials.Veeva

Menu

Medicines Gaps Study (MeGa)

T

The Leeds Teaching Hospitals NHS Trust

Status

Enrolling

Conditions

Adherence, Medication
Statin Adverse Reaction
Anticoagulant Adverse Reaction

Treatments

Behavioral: Questionnaires to report barriers to medication adherence

Study type

Interventional

Funder types

Other

Identifiers

NCT05332158
PH21/145969

Details and patient eligibility

About

The adherence project aims to understand adherence rates and barriers to Direct oral anticoagulants (DOACs) and statins and improve awareness of healthcare professionals on adherence across Leeds.

During the first component of the project, the investigation of rates of non-adherence was classed as service evaluation. The second component of this project, which this IRAS application refers to, will look into patient perspectives and barriers to adherence. Currently, such information is not routinely collected and only requested as part of shorter or longer consultations depending on a pre-defined clinical agenda and with little attention to adherence. Two specific questionnaires have been designed and integrated within the primary care medical records systems. Following invitation for target patients on DOACs and/or statins to respond anonymously, responses to the questionnaire(s) will be stored in their medical records. Data will then be extracted from the two systems [SystmOne and Egton Medical Information Systems (EMIS)] using unique system identifiers, that will be pseudonymised at the time of extraction. All patient pseudonymised information (including medical records system identifiers and responses to the questionnaire) will be extracted by the LTHT Researcher-Pharmacist following access provided by each participating General Practitioner (GP) Practice, based on searches built centrally by the Data Quality Team of the Leeds Clinical Commissioning Group (CCG).

Apart from the dissemination of findings based on the questionnaire, a training package for health professionals will be designed and delivered. The aim of the training is to combine and disseminate all findings of the project, raise awareness on real-world non-adherence prevalence and the common barriers to adherence, demonstrate the usefulness of routine adherence estimation and suggest tools to address non-adherence in daily practice. The objectives of this training will also consider the training needs of healthcare professionals locally, as per the healthcare professionals survey that has been designed and circulated.

Enrollment

3,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients
  • having an active repeat prescription for a DOAC and/or a statin for at least 6 months prior to the date of data extraction
  • a diagnosis of atrial fibrillation (AF) for those on a DOAC and of hypercholesterolemia for those on a statin (to justify the preventive nature of the treatments)

Exclusion criteria

  • Patients with an active repeat prescription for a DOAC and/or a statin for less than 6 months prior to the date of data extraction

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

3,000 participants in 1 patient group

Intervention arm
Experimental group
Description:
A single arm to administer questionnaires for patients barriers to adherence.
Treatment:
Behavioral: Questionnaires to report barriers to medication adherence

Trial contacts and locations

1

Loading...

Central trial contact

Emmanouela Kampouraki, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems